The platelet-activating factor precursor of the injured cornea is selectively implicated in arachidonate and eicosanoid release
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 12 (7) , 655-663
- https://doi.org/10.3109/02713689309001845
Abstract
The purpose of this study was to isolate the platelet-activating factor (PAF) precursor and other choline phosphoglycerides (GPC) i.e. the alkenylacyl and diacyl lipids from the rabbit cornea, to analyze their fatty acid content and to determine which pool was the most susceptible to arachidonate depletion when activated corneal tissue released arachidonic acid (AA) and metabolites. Rabbit iridal GPC was also analyzed for comparative purposes. The fatty acid methyl esters of the GPC components extracted from the rabbit cornea and iris-ciliary body, isolated by high performance liquid chromatography (HPLC), were determined by capillary gas liquid chromatography. Rabbit corneas were labelled in vivo by intracameral injection of 3H-AA (1 microCi, specific activity = 218 Ci/mmol) and cryogenically injured 18 h later. Corneas were incubated in vitro and the AA and eicosanoids released into the medium were extracted and separated by HPLC. The GPC was extracted from the tissues and the labeling of the three GPC constituents was quantified by liquid scintillation counting. The corneal and iridal PAF precursor represented 4.1 +/- 0.2% and 2.9 +/- 0.2% respectively of total GPC in those tissues. On a mole basis, the alkyl arachidonoyl species constituted 12.7 +/- 0.7% of the corneal and 38 +/- 0.6% of the iridal PAF precursors respectively. The release of AA and prostaglandins by the cornea was linear until 15 min; whereas 12-HETE levels continuously increased until 60 min. All GPC components lost label but 1-O-alkyl-2-arachidonoyl was the most affected, with its labeled content 50% less than the non-injured control.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 17 references indexed in Scilit:
- Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acidLipids, 1991
- Platelet-activating factor (PAF) accumulation correlates with injury in the corneaExperimental Eye Research, 1991
- Platelet-activating factor.Journal of Biological Chemistry, 1990
- Quantitative analysis of fatty acids in phospholipids, diacylglycerols, free fatty acids, and other lipidsThe Journal of Nutritional Biochemistry, 1990
- The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase productsBiochemical and Biophysical Research Communications, 1987
- Composition of Alkyl Ether-Linked Phospholipids in Mammalian TissuesPublished by Springer Nature ,1987
- Inhibition of the Alkali Burn-Induced Lipoxygenation of Arachidonic Acid in the Rabbit CorneaIn Vivoby a Platelet Activating Factor AntagonistJournal of Ocular Pharmacology and Therapeutics, 1987
- Separation of phospholipids by high-performance liquid chromatography: All major classes, including ethanolamine and choline plasmalogens, and most minor classes, including lysophosphatidylethanolamineJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle. Inhibition by calcium channel antagonistsBiochemical Journal, 1985
- Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spotsLipids, 1970